Are you confused about the plethora of newly available agents for treatment of lung cancer and when particular agents are indicated?
Are you confused about the variety of biomarkers used to determine the optimal treatment of a particular patient's lung cancer?
Do you want to have access to an organized review of the types of agents and the biomarkers used to determine optimal treatment of lung cancer?
You Will Learn on This Webinar:
- The latest advancements in lung cancer treatment, including targeted therapies and immunotherapies.
- The importance of early detection in improving treatment outcomes for lung cancer.
- The role of biomarker testing and precision medicine in the treatment of lung cancer.
- What are the 3 most important biomarkers currently
- The potential benefits of combination therapies in treating lung cancer.
- The importance of a multidisciplinary approach to lung cancer treatment, involving a team of specialists.
- The latest research and clinical trials in lung cancer treatment, and their potential implications for patient care.
Who is this for?
Thoracic Surgeons
Surgical and Medical Residents
Pulmonologists
Oncologists
Anyone involved in care and treatment of lung cancer patients
Primary Care Physicians
About me:
Dr. Tyler Greenfield
- 30+ years experience with surgical treatment of lung cancer
- I have been working on an organized description of recent advances in lung cancer treatment
- I have used this knowledge in recommending successful treatments to my patients
- I have been a Chairman of our local multidisciplinary thoracic tumor board working closely with medical oncologists and radiation oncologists
- Surgical treatment has traditionally been the mainstay of lung cancer treatment
- Many patients with surgically resected lung cancer recur and it was learned that post-operative or adjuvant chemotherapy extended the survival rate and decreased the recurrence rate
Optimizing Lung Cancer Surgery Outcomes: An organized review of Advanced Pre and Post-Operative Treatment for Recurrence Prevention and Extending Disease-Free Survival
Online Course
My students have been able to apply the knowledge gained to actual patients they have treated.
Testimonials
Mark L.
Thoracic Surgeon
"This course has been an invaluable tool, providing me with the essential knowledge to accurately identify necessary biomarkers. It's also offered clear guidance on how to properly refer patients for adjuvant therapy following surgical resection. Truly, this course has been a game-changer!"
Beryl C.
Medical Student
"I'm absolutely thrilled with Dr. Greenfield's course! It provided a superb and easy-to-grasp review of lung cancer workup, staging, and post-surgical treatment methods. I've learned so much new material that hasn't even been covered in my medical school coursework yet. This has given me an exciting edge in my studies!"
David K.
Pulmonologist
"As a pulmonologist, I'm deeply thankful for this course. It systematically highlighted the significance of biomarker testing for lung cancer patients. Not only did it equip me with critical information, but it also instilled confidence in me to order the appropriate biomarkers for lung cancer patients I conduct diagnostic biopsies on. This course has been incredibly beneficial."
Andrew A.
Oncologist
"As an oncologist, I wholeheartedly endorse this course. It serves as a valuable resource and a reference framework that significantly enhances communication among thoracic surgeons, oncologists, pulmonologists, interventional radiologists, radiation oncologists, and other members of the multidisciplinary teams. This improved collaboration is crucial for providing optimal care to our increasingly diverse and complex lung cancer patients. I'm sincerely grateful for this course and its contribution to our practices."